The microarray facilitates drug screening in cancer stem cells and other rare cell populations.

The New York Times examines ethics and China's push to lead biomedical research.

The arrangement will join Nuclea's expertise in proteomics with Aelan's genomics know-how.

The appeals court agreed with a previous ruling that found New England Biolabs failed to file its lawsuit in a timely manner.

The partners are working to integrate NantHealth's Genomic Proteomic Sequencing and Eviti cancer treatment planning platform with Allscripts' software.

The test is designed to predict prostate cancer aggressiveness and launched in the US in 2013.

Researchers report that what scents someone picks up can reflect their complement of immune genes.

A later change in the protease gene likely enabled the bacterium to cause the invasive infection of bubonic plague.

ImmunArray is launching the SLE-Key Rule Out test to exclude a diagnosis of lupus, a test run on its multiple-antigen microarray-based technology.

Experts at Vanderbilt discussed future expansion of its PREDICT program, and provided a glimpse at how doctors have responded to genomic information in EMRs.

Using genome sequencing data on 30 Brazilians and genotyping information on almost 6,500 more, the Brazilian EPIGEN Project Consortium considered ancestry and admixture patterns in three parts of Brazil.

At her blog, Sally Rockey dives into National Institutes of Health funding data.

Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.

DNAnexus' platform will support data analysis and sharing for the third phase of the Encyclopedia of DNA Elements project.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.

Researchers detected a truncating mutation in the carboxypeptidase E gene in members of a Sudanese family affected by extreme obesity, glucose metabolism problems, and other symptoms.

10X Genomics has started shipping the GemCode platform for generating long range genomic information from short read sequencing data. The platform consists of instrumentation, reagents, and software and generates so-called Linked-Reads that deliver haplotype phasing, structural variation, and other genomic information. GemCode, which requires 1 nanogram of input DNA, partitions arbitrarily long DNA molecules and prepares multiple barcoded sequencing libraries in parallel. 10X Genomics previewed the product earlier this year at the Advances in Genome Biology and Technology conference.

Exiqon has launched a quantitative PCR product portfolio, ExiLERATE LNA, enabling real-time PCR analysis of mRNAs and long non-coding RNA. The suite of products supports sample isolation, cDNA generation, real-time PCR amplification, and detection, and is compatible with all major real-time PCR instruments. It includes endogenous controls and supports custom assay design facilitated by an assay design tool called XploreRNA.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

The reagent supplier now has three Japanese distributors following a 2013 deal with GeneDesign as a representative throughout that country.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Therapies aimed at drug targets that have been linked genetically to disease fare better through the drug development pipeline, researchers from GSK and elsewhere found.

A Mount Sinai-led team of researchers combined the technologies to generate de novo assemblies and get a better view of structural variations.

Through its agreement with Quest Diagnostics, the company plans to launch a BRCA1/2 test, followed by tests for Lynch syndrome and HPV. 

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.